Waters Corp (WAT)
302.15
-6.48
(-2.10%)
USD |
NYSE |
Mar 22, 16:00
302.15
0.00 (0.00%)
After-Hours: 19:26
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 17.81B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -8.71% |
| Valuation | |
| PE Ratio | 25.71 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 6.133 |
| Price to Book Value | 35.30 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 3.122 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.54% |
News
Headline
Wire
Time (ET)
Yahoo
03/20 08:00
Yahoo
03/20 07:55
Yahoo
03/15 09:00
Yahoo
03/03 05:26
Yahoo
03/03 05:23
Yahoo
02/23 10:19
MT Newswires
02/16 13:10
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/03/2023* | -- | Results | Q1 2023 | -- | 2.63 | -- | |
| 05/03/2023* | 08:00 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 02/15/2023 | -- | Results | Q4 2022 | 3.84 | 3.74 | 2.57% | |
| 02/15/2023 | 08:00 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 11/01/2022 | -- | Results | Q3 2022 | 2.64 | 2.58 | 2.38% | |
| 11/01/2022 | 08:00 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 08/02/2022 | -- | Results | Q2 2022 | 2.75 | 2.67 | 3.09% | |
| 08/02/2022 | 08:00 EST | Earnings Call | Q2 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2021, Waters generated 60% from pharmaceutical customers, 30% from industrial clients, and 10% from academic/government institutions. |
| URL | https://www.waters.com |
| Investor Relations URL | https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | May. 03, 2023 (est.) |
| Last Earnings Release | Feb. 15, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 26, 1996 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.00 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | Nov. 26, 1996 |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 21, 2023.
Fundamentals
| Revenue (TTM) | 2.972B |
| Total Expenses (TTM) | 2.089B |
| Net Income (TTM) | 707.76M |
| Total Assets (Quarterly) | 3.281B |
| Total Liabilities (Quarterly) | 2.777B |
| Shareholders Equity (Quarterly) | 504.49M |
| Cash from Operations (TTM) | 611.66M |
| Cash from Investing (TTM) | -107.97M |
| Cash from Financing (TTM) | -509.63M |
Ratings
Profile
Edit
| Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2021, Waters generated 60% from pharmaceutical customers, 30% from industrial clients, and 10% from academic/government institutions. |
| URL | https://www.waters.com |
| Investor Relations URL | https://www.waters.com/waters/en_US/Investors/nav.htm?cid=134614445&locale=en_US |
| HQ State/Province | Massachusetts |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | May. 03, 2023 (est.) |
| Last Earnings Release | Feb. 15, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 26, 1996 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| PHO | 68.79M USD | 3.99% |
| PIO | 9.947M USD | 3.69% |
| MAW108 | 133.79M USD | 3.03% |
| MMF1262 | 35.82M USD | 2.99% |
| CIPMX | 135.32M USD | 2.55% |
| PXEAX | 57.73M USD | 2.40% |
| NUMG | 7.440M USD | 2.15% |
| ATL774 | 49.01M USD | 2.04% |
| IBB | 143.08M USD | 1.80% |
| IHI | 95.07M USD | 1.65% |
| BMEZ | 30.35M USD | 1.53% |
| AULNX | 155.87M USD | 1.06% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| WAT Tweets |